Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

shutterstock_38078521

Bavencio+Inlyta combo boosts progression-free survival in advanced kidney cancer

February 18, 2019
Research and Development, Sales and Marketing Bavencio, Cancer, Kidney cancer, Merck KGaA, Pfizer, inlyta, pharma

New interim data for the combination of Pfizer’s Bavencio (avelumab) and Merck KGaA’s Inlyta (axitinib) have been released, showing that …

News
merckwindow_web

MSD’s Keytruda combo therapy significantly improves survival in advanced renal cell carcinoma

February 18, 2019
Sales and Marketing Cancer, MSD, Merck Sutent, Pfizer, inlyta, keytruda, oncology, rcc, renal cell carcinoma

Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced renal …

News
takeda_usa_pharmaceuticals_u

Takeda’s Adcetris secures expanded approval in Europe for untreated CD30+ Stage IV Hodgkin lymphoma

February 14, 2019
Sales and Marketing Adcetris, Cancer, Europe, Hodgkin lymphoma, Takeda, pharma

Takeda’s Adcetris (brentuximab vedotin) has seen its marketing authorisation expanded by the European Commission to include the treatment of previously …

News

J&J acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal

February 14, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Auris Health, Cancer, J&J, JJ, lung cancer, pharma, robotics

In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics …

News

BMS scores expanded European approval for Sprycel in paediatric leukaemia

February 13, 2019
Research and Development, Sales and Marketing BMS, Cancer, Europe, Sprycel, leukaemia, pharma

Bristol-Myers Squibb’s Sprycel (dasatinib) has secured an expanded indication in Europe, the company said, with the European Commission greenlighting the …

News
101817_tumorsmyeloidsuppressorcells

Researchers find new type of cell membrane which causes cancer cells to explode

February 13, 2019
Research and Development Cancer, FTY720, cell membranes, molecules, oncology

Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …

News
image_credit_-_rafael_matsunaga

Clinigen shares soar after $210m Novartis cancer drug deal

February 13, 2019
Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

News
scotland

Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland

February 12, 2019
Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma

It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …

News
merck-keytruda

Keytruda + Inlyta combo beats Pfizer’s chemotherapy Sutent in renal cell carcinoma

February 12, 2019
Manufacturing and Production, Research and Development Cancer, MSD, Pfizer, inlyta, keytruda, pharma, renal cell carcinoma

New data has been revealed on the efficacy of MSD’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib), showing it …

News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019
Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …

News
shutterstock_3

FDA warns over breast implant cancer risk after nine deaths confirmed

February 8, 2019
Medical Communications, Research and Development Cancer, FDA, breast implants, pharma

The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …

News
genentech_web

Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m

February 6, 2019
Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …

News
acute_lymphoblastic_leukaemia_smear

Obesity-related cancers on the rise amongst millennials

February 4, 2019
Sales and Marketing Cancer, obesity, oncology, young people

Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

News
kymriah

Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma

February 1, 2019
Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026